Inflation in Britain fell by less than expected in April and a key core measure barely dropped, sparking a jump in the pound and in British government bond yields, as well as prompting investors to ...

London stocks slipped on Wednesday as slower-than-expected deceleration in Britain's inflation knocked off hopes of a June interest rate cut, while Marks & Spencer's gains after the retailer reported ...

Swiss Life has made a good start to the 2024 financial year,” says Matthias Aellig, Group CEO of Swiss Life. “We achieved a substantial increase in fee income in the first ...

Baloise Holding AG / Key word (s): Miscellaneous Baloise proves to be a reliable partner for occupational pensions once again in 2023 22.05.2024 / 07:00 CET/CEST ...

By Pierre Bertrand Sandoz said it has received marketing approval by the European Commission for its treatments of cancer-related bone disease ...

This is the very reason why the country has never been able to come close to the widely narrated and assumed potential – both ...

Specialist Risk Group (SRG), a specialist insurance intermediary, yesterday announced that it had signed a definitive ...

The call covered FY 2023 financial and operational results, as well as significant projects and strategic initiatives that WISeKey is executing to drive innovation and growth in 2024 and beyond, ...

Goldman Sachs analysts warn that surging investor confidence, reflected in their record "Risk Appetite Indicator" (RAI), could limit future returns for the stock market.

Activist fund Cevian Capital AB became a major shareholder in Baloise Holding AG, marking its second big investment in the Swiss finance industry after recently taking a stake in UBS Group AG.

Switzerland-based Limula has raised $6.8mn to further develop its technology that aims to automate cell therapy manufacturing.